{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:30Z","timestamp":1793686350710,"version":"4.5.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.atherosclerosis.2024.117626","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T06:08:11Z","timestamp":1718431691000},"page":"117626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults: Results from a large population-based study"],"prefix":"10.1016","volume":"396","author":[{"given":"Niv","family":"Ben-Shabat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Krasun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan Shneor","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2392-3661","authenticated-orcid":false,"given":"Ilana","family":"Balassiano Strosberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Watad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Beinart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-7716","authenticated-orcid":false,"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117626_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","article-title":"Anti-Ro\/SSA and La\/SSB antibodies","volume":"38","author":"Franceschini","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.atherosclerosis.2024.117626_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.curtheres.2014.06.004","article-title":"The prevalence of antinuclear antibodies in the general population of China: a cross-sectional study","volume":"76","author":"Guo","year":"2014","journal-title":"Curr. Ther. Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117626_bib3","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117626_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","article-title":"Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period","volume":"18","author":"Hayashi","year":"2008","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117626_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/CRD.0b013e31823c808b","article-title":"Cardiac Manifestations of neonatal lupus: a review of autoantibody associated congenital heart block and its impact in an adult population","volume":"20","author":"Capone","year":"2012","journal-title":"Cardiol. Rev."},{"issue":"6173","key":"10.1016\/j.atherosclerosis.2024.117626_bib6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.1.6173.1235","article-title":"Congenital heart block and maternal systemic lupus erythematosus","volume":"1","author":"Esscher","year":"1979","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117626_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.CIR.56.1.82","article-title":"Congenital heart block in newborns of mothers with connective tissue disease","volume":"56","author":"McCue","year":"1977","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117626_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11926-007-0003-4","article-title":"Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus","volume":"9","author":"Friedman","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"issue":"47","key":"10.1016\/j.atherosclerosis.2024.117626_bib9","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1093\/eurheartj\/ehac575","article-title":"Anti-Ro\/SSA-antibodies and heart rhythm disturbances in the general population: the \u2018dark side of the immune.\u2019","volume":"43","author":"Lazzerini","year":"2022","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117626_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autrev.2009.03.002","article-title":"Arrhythmogenic effects of anti-Ro\/SSA antibodies on the adult heart: more than expected?","volume":"9","author":"Lazzerini","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117626_bib11","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.hrthm.2011.06.032","article-title":"Autoantibodies and cardiac arrhythmias","volume":"8","author":"Lee","year":"2011","journal-title":"Heart Rhythm"},{"issue":"47","key":"10.1016\/j.atherosclerosis.2024.117626_bib12","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1093\/eurheartj\/ehac516","article-title":"Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances","volume":"43","author":"Akuka","year":"2022","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117626_bib13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjcard.2007.04.048","article-title":"Comparison of Frequency of Complex Ventricular arrhythmias in patients with positive versus Negative anti-Ro\/SSA and connective tissue disease","volume":"100","author":"Lazzerini","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117626_bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/acr.20540","article-title":"Anti-Ro\/SSA\u2013associated corrected QT interval prolongation in adults: the role of antibody level and specificity","volume":"63","author":"Lazzerini","year":"2011","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117626_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.20130","article-title":"Prolongation of the corrected QT interval in adult patients with anti-Ro\/SSA\u2013positive connective tissue diseases","volume":"50","author":"Lazzerini","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117626_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018735","article-title":"Risk of QTc interval prolongation associated with circulating anti\u2010Ro\/SSA antibodies among US Veterans: an observational cohort study","volume":"10","author":"Lazzerini","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117626_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003419","article-title":"Arrhythmogenicity of Anti-Ro\/SSA Antibodies in Patients With Torsades de Pointes","volume":"9","author":"Lazzerini","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117626_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5152\/eurjrheum.2018.18019","article-title":"Anti-Ro antibodies and complete heart block in adults with Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Jobling","year":"2018","journal-title":"Eur J Rheumatol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117626_bib19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/acr.20470","article-title":"Prolonged corrected QT interval in anti-Ro\/SSA\u2013positive adults with systemic lupus erythematosus","volume":"63","author":"Bourr\u00e9-Tessier","year":"2011","journal-title":"Arthritis Care Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117626_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/diagnostics10070478","article-title":"A Broader perspective on anti-Ro antibodies and their Fetal Consequences\u2014a case Report and Literature review","volume":"10","author":"Popescu","year":"2020","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117626_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117626_bib22","first-page":"48","article-title":"Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block","volume":"202","author":"Clancy","year":"1950","journal-title":"J. Immunol. Baltim Md"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117626_bib23","first-page":"2413","article-title":"Impaired clearance of apoptotic cardiocytes is linked to anti-SSA\/Ro and -SSB\/La antibodies in the pathogenesis of congenital heart block","volume":"116","author":"Clancy","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117626_bib24","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.4049\/jimmunol.165.9.5345","article-title":"Anti-SSA\/ro and anti-SSB\/La autoantibodies Bind the surface of apoptotic Fetal cardiocytes and promote secretion of TNF-\u03b1 by Macrophages1","volume":"165","author":"Miranda-Car\u00fas","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.atherosclerosis.2024.117626_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2014.11.002","article-title":"Anti-Ro\/SSA antibodies and cardiac rhythm disturbances: present and future perspectives","volume":"184","author":"Santos-Pardo","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117626_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","article-title":"The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia","volume":"28","author":"Hahn","year":"2007","journal-title":"J. Autoimmun."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2024.117626_bib27","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117626_bib28","first-page":"404","article-title":"Prevalence of selected chronic diseases in Israel","volume":"3","author":"Rennert","year":"2001","journal-title":"Isr Med. Assoc. J. IMAJ"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117626_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/01.CIR.90.2.694","article-title":"Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation","volume":"90","author":"Vaddi","year":"1994","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117626_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20080196","article-title":"Role of TNF-\u03b1 in vascular dysfunction","volume":"116","author":"Zhang","year":"2009","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117626_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12967-017-1191-y","article-title":"Apoptosis in ischemic heart disease","volume":"15","author":"Teringova","year":"2017","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117626_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(95)05713-7","article-title":"Serum levels of the TGF-beta receptor are increased in atherosclerosis","volume":"120","author":"Blann","year":"1996","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117626_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2008.08.004","article-title":"Cardiovascular involvement in systemic autoimmune diseases","volume":"8","author":"Sitia","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.atherosclerosis.2024.117626_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-023-06686-6","article-title":"Risk factors for cardiovascular disease in primary Sj\u00f6gren\u2019s syndrome (pSS): a 20-year follow-up study","author":"Santos","year":"2023","journal-title":"Clin. Rheumatol. [Internet]"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117626_bib35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/0961203310367504","article-title":"Cardiovascular risk factors in primary Sj\u00f6gren\u2019s syndrome: a case-control study in 624 patients","volume":"19","author":"P\u00e9rez-De-Lis","year":"2010","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117626_bib36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/joim.12941","article-title":"Concomitant Ro\/SSA and La\/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sj\u00f6gren\u2019s syndrome","volume":"286","author":"Mofors","year":"2019","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117626_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000864","article-title":"Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE","volume":"10","author":"Panopoulos","year":"2023","journal-title":"Lupus Sci. Med."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117626_bib38","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/rheumatology\/ker285","article-title":"Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus","volume":"50","author":"Kiani","year":"2011","journal-title":"Rheumatology"},{"issue":"27","key":"10.1016\/j.atherosclerosis.2024.117626_bib39","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117626_bib40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117626_bib41","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2024.117626_bib42","unstructured":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States - Satoh - 2012 - Arthritis & Rheumatism - Wiley Online Library [Internet]. [cited 2023 Jul 29]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/art.34380."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2024.117626_bib43","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2024.117626_bib44","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMp038142","article-title":"Autoantibodies in systemic lupus erythematosus--there before you know it","volume":"349","author":"Shmerling","year":"2003","journal-title":"N. Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024001941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024001941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T13:48:44Z","timestamp":1727704124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024001941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":44,"alternative-id":["S0021915024001941"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117626","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults: Results from a large population-based study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117626"}}